2023 Pipeline Report
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
Broadly Neutralizing Antibodies (bNAbs) and HIV Cure-Related Research
HIV has evolved multiple mechanisms to evade inhibition by antibodies, which are Y-shaped immune system proteins that normally play a key role in fending off or controlling infections.
Open Letter: Urgent Action Necessary for Equitable Access to Bedaquiline in All Countries with High Burdens of TB, MDR-TB, and TB/HIV
TAG and 82 other organizations and 106 individuals representing TB-affected communities and civil society sent an open letter to Johnson & Johnson calling on the company...
2022 Annual Report
As we close another year of unprecedented challenges and achievements, I'm honored to share with you Treatment Action Group's (TAG) 2022 Annual Report.
Treatment Action Group Welcomes Moe Ari Brown as Newest Board Member
Treatment Action Group (TAG) is pleased to announce the election of Moe Ari Brown to our Board of Directors.
TAG’s Submission to OHCHR for GA78 Report
TAG recently submitted this input for the Office of the High Commissioner on Human Rights (ONHCR) Independent Expert on Foreign Debt and Human Rights thematic report for the UN General Assembly 78 later this year.
Research in Action Awards 2023
Save the date for Monday, October 19! TAG’s 2023 Research in Action Awards will honor some of the best and brightest activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C across the U.S. and around the world.
35 Years of Art to End AIDS Exhibition Catalog
TAG is presenting the exhibition “35 Years of Art to End AIDS” at Melissa Morgan Fine Art in Palm Desert, California, from March 17 through April 7, 2023. This exhibit features selected works form our Limited Art Editions collection.
HIV Cure Research Information Sheet
Research into curing HIV infection is ever-changing as new discoveries are made and scientists report additional rare — but informative — cases of individuals likely cured of HIV.
Why Viral Load Can Be Detectable Despite Perfect Adherence
Webinar on March 22 that will provide an update on new research into cases in which the HIV reservoir generates detectable viral load that cannot be suppressed by antiretroviral therapy.